In a French open-label non-randomized clinical trial, more patients treated with HCQ tested negative for COVID-19 by day 6 after inclusion in study

In a Chinese small randomized clinical trial, researchers reported a faster mean time to clinical recovery in the experimental group treated with HCQ than in the control group

In a French uncontrolled, non-comparative, observational study, a significant decline of nasopharyngeal viral load and viral carriage duration was noted in patients treated with both HCQ and azithromycin (azm)